Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 30.85%9.81B | 41.45%10.32B | 40.53%9.54B | 41.46%30.38B | 42.31%8.8B | 37.42%7.5B | 43.48%7.3B | 42.81%6.79B | 37.39%21.48B | 42.45%6.18B |
Cost of revenue | 19.63%3.27B | 26.97%3.47B | 19.24%3B | 39.84%11.3B | 34.35%3.31B | 28.11%2.74B | 46.33%2.73B | 56.26%2.52B | 67.83%8.08B | 55.77%2.46B |
Gross profit | 37.30%6.53B | 50.12%6.85B | 53.08%6.54B | 42.43%19.08B | 47.59%5.49B | 43.42%4.76B | 41.82%4.56B | 35.91%4.27B | 23.84%13.4B | 34.80%3.72B |
Operating expense | 23.35%7.54B | 25.05%7.69B | 27.73%7.53B | 16.21%25.41B | 23.33%7.25B | 4.92%6.12B | 14.35%6.15B | 23.32%5.9B | 84.05%21.87B | 71.99%5.88B |
Operating profit | 25.59%-1.01B | 47.24%-835.02M | 38.93%-992.56M | 25.26%-6.33B | 18.37%-1.77B | 45.97%-1.36B | 26.63%-1.58B | 0.83%-1.63B | -697.29%-8.47B | -227.10%-2.16B |
Net non-operating interest income (expenses) | 72.35%-39.24M | 5.24%-34.61M | -25.38%-34.15M | -180.79%-243.25M | -35.81%-37.57M | -450.64%-141.92M | -93.43%-36.52M | -90.30%-27.24M | 76.08%-86.63M | -110.14%-27.67M |
Non-operating interest income | 1,207.60%3.27M | 1,246.25%1.08M | 522.09%1.07M | 134.43%1.29M | 336.11%785K | 46.20%250K | 185.71%80K | 1.18%172K | 603.85%549K | 3,500.00%180K |
Non-operating interest expense | 15.46%42.51M | -2.50%35.68M | 28.50%35.22M | 58.31%131.48M | 29.22%30.65M | 41.92%36.82M | 93.57%36.6M | 89.26%27.41M | 71.87%83.05M | 80.10%23.72M |
Total other finance cost | ---- | ---- | ---- | 2,640.04%113.05M | --7.71M | ---- | ---- | ---- | -98.69%4.13M | ---- |
Net investment income | 180.43%40.72M | -147.70%-37.24M | -201.50%-24.23M | 33.80%-59.07M | -255.24%-17.28M | 13.82%-50.62M | 33.31%-15.04M | 877.24%23.87M | -89.22M | -4.86M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -19,083.69%-44.23M | -119.51%-40.66M | 0 | -77.70%-39.18M | -1,027.71%-10.09M | 111.02%233K | 7.24%-18.52M | -1,260.75%-10.8M | -786.18%-22.05M | -112.72%-895K |
Income from associates and other participating interests | -181.46%-92.15M | -63.79%-59.67M | -151.22%-86.85M | 92.31%-70.91M | 190.19%32.84M | 96.30%-32.74M | -18,298.99%-36.43M | -18,192.59%-34.57M | -922.06M | -36.41M |
Special income (charges) | -193.41%-723K | -58.68%-10M | 123.74%208K | -94.72%-66.36M | -71.09%-59.95M | 774K | -2,746.64%-6.3M | -220.33%-876K | -1,484.12%-34.08M | -13,842.35%-35.04M |
Less:Other special charges | 193.41%723K | 58.68%10M | -123.74%-208K | 94.72%66.36M | 71.09%59.95M | ---774K | 2,746.64%6.3M | 220.33%876K | 1,484.12%34.08M | 13,842.35%35.04M |
Other non-operating income (expenses) | -83.80%2.14M | 80.40%-2.97M | -31.81%2.54M | -58.40%3.21M | -80.83%1.43M | 1,075.13%13.19M | -1,182.71%-15.14M | 1,126.32%3.73M | 168.25%7.71M | 137.93%7.47M |
Income before tax | 27.09%-1.14B | 40.37%-1.02B | 32.08%-1.14B | 29.23%-6.81B | 17.88%-1.86B | 54.97%-1.57B | 22.93%-1.71B | -1.00%-1.67B | -572.39%-9.62B | -232.20%-2.26B |
Income tax | 168.46%68.63M | -89.06%4.5M | 20.84%111.83M | -36.78%54.47M | -44.88%-104.78M | -20.68%25.56M | -26.88%41.14M | 32.23%92.54M | -43.49%86.16M | -177.21%-72.32M |
Net income | 23.95%-1.21B | 41.51%-1.02B | 29.30%-1.25B | 29.29%-6.86B | 19.96%-1.75B | 54.66%-1.59B | 23.03%-1.75B | -2.27%-1.76B | -513.05%-9.7B | -182.65%-2.19B |
Net income continuous operations | 23.95%-1.21B | 41.51%-1.02B | 29.30%-1.25B | 29.29%-6.86B | 19.96%-1.75B | 54.66%-1.59B | 23.03%-1.75B | -2.27%-1.76B | -513.05%-9.7B | -182.65%-2.19B |
Noncontrolling interests | -148.73%-96.69M | 432.43%253.79M | 224.77%72M | -116.19%-544.77M | -344.70%-371.85M | 30.14%-38.87M | -33.78%-76.35M | -3.67%-57.7M | -151.26%-251.98M | -66.24%-83.62M |
Net income attributable to the company | 28.27%-1.11B | 23.70%-1.28B | 22.69%-1.32B | 33.17%-6.32B | 34.45%-1.38B | 55.05%-1.55B | 24.49%-1.68B | -2.23%-1.71B | -537.53%-9.45B | -190.74%-2.1B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 28.27%-1.11B | 23.70%-1.28B | 22.69%-1.32B | 33.17%-6.32B | 34.45%-1.38B | 55.05%-1.55B | 24.49%-1.68B | -2.23%-1.71B | -537.53%-9.45B | -190.74%-2.1B |
Gross dividend payment | ||||||||||
Basic earnings per share | 28.82%-20.45 | 24.32%-23.5 | 23.32%-24.33 | 33.70%-116.98 | 34.89%-25.47 | 55.48%-28.73 | 25.18%-31.05 | -1.44%-31.73 | -488.72%-176.44 | -174.91%-39.12 |
Diluted earnings per share | 28.82%-20.45 | 24.32%-23.5 | 23.32%-24.33 | 33.70%-116.98 | 34.88%-25.4838 | 55.48%-28.73 | 25.18%-31.05 | -1.44%-31.73 | -488.72%-176.44 | -174.99%-39.1314 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |